Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Eosinophilic esophagitis: dilate or medicate? A cost analysis model of the choice of initial therapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Eosinophilic esophagitis: dilate or medicate? A cost analysis model of the choice of initial therapy.
Eosinophilic esophagitis: dilate or medicate? A cost analysis model of the choice of initial therapy. Dis Esophagus. 2014 Jul; 27(5):418-23.
View in:
PubMed
subject areas
Androstadienes
Anti-Inflammatory Agents
Costs and Cost Analysis
Decision Trees
Deglutition Disorders
Dilatation
Endoscopy, Digestive System
Eosinophilic Esophagitis
Esophageal Stenosis
Fluticasone
Hospitalization
Humans
Metered Dose Inhalers
Tennessee
authors with profiles
Robert T. Kavitt